Kodiak Sciences (FRA:K27) Beginning Cash Position : €322.78 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kodiak Sciences Beginning Cash Position?

Kodiak Sciences's Beginning Cash Position for the quarter that ended in Dec. 2023 was €322.78 Mil.

Kodiak Sciences's quarterly Beginning Cash Position increased from Jun. 2023 (€298.07 Mil) to Sep. 2023 (€360.74 Mil) but then declined from Sep. 2023 (€360.74 Mil) to Dec. 2023 (€322.78 Mil).

Kodiak Sciences's annual Beginning Cash Position declined from Dec. 2021 (€841.39 Mil) to Dec. 2022 (€696.52 Mil) and declined from Dec. 2022 (€696.52 Mil) to Dec. 2023 (€180.43 Mil).

Kodiak Sciences Beginning Cash Position Historical Data

The historical data trend for Kodiak Sciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kodiak Sciences Beginning Cash Position Chart

Kodiak Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

79.55

174.21

841.39

696.52

180.43

Kodiak Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															174.39	183.77	298.07	360.74	322.78

Kodiak Sciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Kodiak Sciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Kodiak Sciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kodiak Sciences (FRA:K27) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (FRA:K27) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

KOD:USA K27:Germany

Address

1200 Page Mill Road, Palo Alto, CA, USA, 94304

Website

https://www.kodiak.com

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Kodiak Sciences (FRA:K27) Headlines

No Headlines